Go Pro

Compass Financial Management LLC Buys New Position in Cigna Group $CI

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Compass Financial Management initiated a position in Cigna Group during the second quarter, purchasing 4,254 shares valued at approximately $1.17 million. Institutional investors collectively own 86.99% of Cigna’s outstanding stock.
  • Cigna reported quarterly EPS of $7.78, exceeding estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company maintained fiscal 2026 EPS guidance of roughly $30.45 and analysts hold a “Moderate Buy” consensus with a $339.45 price target.
  • Cigna declared a quarterly dividend of $1.56 per share, equivalent to $6.24 annually and a 2.2% yield. Shares recently traded around $282.24, down 1.4%, while insiders sold 23,012 shares worth approximately $6.39 million over the last quarter.
  • Five stocks we like better than Cigna Group.

Compass Financial Management LLC bought a new stake in Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 4,254 shares of the health services provider's stock, valued at approximately $1,173,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. NBH Bank purchased a new position in shares of Cigna Group in the second quarter valued at approximately $49,000. AlphaGrep UK Ltd purchased a new stake in Cigna Group during the 2nd quarter worth approximately $408,000. Shah Wealth Advisors LLC acquired a new stake in Cigna Group during the 2nd quarter worth approximately $819,000. Markowski Investments acquired a new stake in Cigna Group during the 2nd quarter worth approximately $85,000. Finally, TOP Private Wealth LLC. purchased a new position in Cigna Group in the 2nd quarter valued at approximately $68,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Down 1.4%

Shares of NYSE:CI opened at $282.24 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company's 50 day moving average is $283.51 and its two-hundred day moving average is $281.07. The company has a market cap of $74.58 billion, a PE ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.31. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analysts' expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's dividend payout ratio is presently 25.82%.

Analyst Ratings Changes

Several research firms have commented on CI. Barclays boosted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Piper Sandler decreased their target price on Cigna Group from $370.00 to $346.00 and set an "overweight" rating for the company in a report on Wednesday, June 3rd. Robert W. Baird set a $362.00 target price on Cigna Group in a research note on Friday, July 31st. Wall Street Zen raised Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 29th. Finally, Wolfe Research restated an "outperform" rating and set a $315.00 price target on shares of Cigna Group in a report on Tuesday, June 16th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $339.45.

View Our Latest Analysis on CI

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company's stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company's stock.

Cigna Group Company Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines